Leptomeningeal carcinomatosis from gastric cancer successfully treated by the intrathecal methotrexate plus temozolomide and simultaneous radiotherapy: Case report and literatures review

References

• Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer treatment reviews. 1999;25(2):103-19. doi:10.1053/ctrv.1999.0119.
   PubMed Web of Science ®Google Scholar
• Pentheroudakis G, Pavlidis N. Management of leptomeningeal malignancy. Expert Opin Pharmacother. 2005;6(7):1115-25. doi:10.1517/14656566.6.7.1115.
   PubMed Web of Science ®Google Scholar
• Chamberlain MC. Leptomeningeal metastasis. Paper presented at: Seminars in neurology 2010.
   Google Scholar
• Kim M. Intracranial involvement by metastatic advanced gastric carcinoma. J Neurooncol. 1999;43(1):59-62. doi:10.1023/A:1006156204385.
   PubMed Web of Science ®Google Scholar
• Groves MD. New strategies in the management of leptomeningeal metastases. Arch Neurol. 2010;67(3):305-12. doi:10.1001/archneurol.2010.18.
   PubMedGoogle Scholar
• Kak M, Nanda R, Ramsdale EE, Lukas RV. Treatment of leptomeningeal carcinomatosis: Current challenges and future opportunities. J Clin Neurosci. 2015;22(4):632-7. doi:10.1016/j.jocn.2014.10.022.
   PubMed Web of Science ®Google Scholar
• Lisenko Y, Kumar AJ, Yao J, Ajani J, Ho L. Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature. Am J Clin Oncol. 2003;26(2):165-70. doi:10.1097/00000421-200304000-00013.
   PubMed Web of Science ®Google Scholar
• Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD. Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005;103(11):2355-62. doi:10.1002/cncr.21082.
   PubMed Web of Science ®Google Scholar
• Oh SY, Lee S-J, Lee J, Lee S, Kim SH, Kwon HC, Lee GW, Kang JH, Hwang IG, Jang JS, et al. Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 cases. World J Gastroenterol. 2009;15(40):5086-90. doi:10.3748/wjg.15.5086.
   PubMed Web of Science ®Google Scholar
• Park K-K, Yang S-I, Seo K-W, Kim Y-O, Yoon K-Y. A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma. World journal of surgical oncology. 2012;10(1):74. doi:10.1186/1477-7819-10-74.
   PubMed Web of Science ®Google Scholar
• Bulut G, Erden A, Karaca B, Göker E. Leptomeningeal carcinomatosis of gastric adenocarcinoma. Turk J Gastroenterol. 2011;22(2):195-8. doi:10.4318/tjg.2011.0191.
   PubMed Web of Science ®Google Scholar
• Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49(4):759-72. doi:10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7.
   PubMed Web of Science ®Google Scholar
• Chamberlain MC. Leptomeningeal metastasis. Current Opin Oncol. 2010;22(6):627-35. doi:10.1097/CCO.0b013e32833de986.
   PubMed Web of Science ®Google Scholar
• Vergoulidou M. Leptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical Challenge. Biomark Insights. 2017;12:1177271917695237. doi:10.1177/1177271917695237.
   Web of Science ®Google Scholar
• Kim S-J, Kwon J-T, Mun S-K, Hong Y-H. Leptomeningeal carcinomatosis of gastric cancer misdiagnosed as vestibular schwannoma. J Korean Neurosurg Soc. 2014;56(1):51-4. doi:10.3340/jkns.2014.56.1.51.
   PubMed Web of Science ®Google Scholar
• Groves MD. New strategies in the management of leptomeningeal metastases. Arch Neurol. 2010;67(3):305-12. doi:10.1001/archneurol.2010.18.
   PubMedGoogle Scholar
• Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1987;5(10):1655-62. doi:10.1200/JCO.1987.5.10.1655.
   PubMed Web of Science ®Google Scholar
• Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. Lancet Oncol. 2010;11(9):871-9. doi:10.1016/S1470-2045(10)70034-6.
   PubMed Web of Science ®Google Scholar
• Lassman AB, Abrey LE, Shah GD, Panageas KS, Begemann M, Malkin MG, Raizer JJ. Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol. 2006;78(3):255-60. doi:10.1007/s11060-005-9044-6.
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Investigation. 2005;23(2):145-54. doi:10.1081/CNV-50458.
   PubMed Web of Science ®Google Scholar
• Kak M, Nanda R, Ramsdale EE, Lukas RV. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2015;22(4):632-7. doi:10.1016/j.jocn.2014.10.022.
   PubMed Web of Science ®Google Scholar
• Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clinical cancer research: an official journal of the American Association for Cancer Research. 2004;10(11):3728-36. doi:10.1158/1078-0432.CCR-03-0807.
   PubMed Web of Science ®Google Scholar
• Ma W, Li N, An Y, Zhou C, Bo C, Zhang G. Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis. World Neurosurg. 2016;92:197-205. doi:10.1016/j.wneu.2016.04.011.
   PubMed Web of Science ®Google Scholar
• Segura PP, Gil M, Balana C, Chacón I, Langa JM, Martín M, Bruna J. Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors. J Neurooncol. 2012;109(1):137-42. doi:10.1007/s11060-012-0879-3.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Zustovich F, Della Puppa A, Borgato L, Orvieto E, Manara R, Cecchin D, Berti F, Farina P, Gardiman MP, et al. Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma. J Neurooncol. 2011;104(1):381-6. doi:10.1007/s11060-010-0484-2.
   PubMed Web of Science ®Google Scholar
• Hottinger AF, Favet L, Pache JC, Martin JB, Dietrich PY. Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis. Case Rep Oncol. 2011;4(1):211-5. doi:10.1159/000327699.
   PubMedGoogle Scholar